M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 3.26 USD -0.31% Market Closed
Market Cap: 161.4m USD

Wall Street
Price Targets

MDXH Price Targets Summary
MDxHealth SA

Wall Street analysts forecast MDXH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXH is 7.18 USD with a low forecast of 4.24 USD and a high forecast of 9.45 USD.

Lowest
Price Target
4.24 USD
30% Upside
Average
Price Target
7.18 USD
120% Upside
Highest
Price Target
9.45 USD
190% Upside
MDxHealth SA Competitors:
Price Targets
FOLD
Amicus Therapeutics Inc
14% Upside
145020
Hugel Inc
50% Upside
603087
Gan & Lee Pharmaceuticals
8% Downside
SOBI
Swedish Orphan Biovitrum AB (publ)
4% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
45% Upside
ALXO
ALX Oncology Holdings Inc
127% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
20% Upside
XNCR
Xencor Inc
107% Upside

Revenue
Forecast

Revenue Estimate
MDxHealth SA

For the last 13 years the compound annual growth rate for MDxHealth SA's revenue is 28%. The projected CAGR for the next 4 years is 21%.

28%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
MDxHealth SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXH's stock price target?
Price Target
7.18 USD

According to Wall Street analysts, the average 1-year price target for MDXH is 7.18 USD with a low forecast of 4.24 USD and a high forecast of 9.45 USD.

What is MDxHealth SA's Revenue forecast?
Projected CAGR
21%

For the last 13 years the compound annual growth rate for MDxHealth SA's revenue is 28%. The projected CAGR for the next 4 years is 21%.

Back to Top